Status:
COMPLETED
TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer
Lead Sponsor:
Steven Isakoff, MD, PhD
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to see if Near-Infrared Tomographic Optical Breast Imaging (TOBI) scans can help monitor breast tumor response during treatment for breast cancer. The images crea...
Detailed Description
* Participants will have a TOBI scan prior to starting their cancer treatment and again on day 8 after their first treatment. Participants will also be asked if they would volunteer to undergoing one ...
Eligibility Criteria
Inclusion
- Adult female patients presenting to the MGH Cancer Center Gillette Center for breast cancer neoadjuvant therapy
- Subject who have had or will have a clinically indicated pre-treatment breast MRI
Exclusion
- Younger than 18 years of age
- Open wounds on breast
- Breast implants, because they may interfere with readings
- Subjects who will be receiving preoperative therapy for \<28 days
- Breast surgery or biopsy \< 10 days prior to optical imaging scan
- Medical or psychiatric or other medical condition that the principal investigator believes may result in inability to complete the study
- Bilateral breast cancers or a history of contralateral breast cancer
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00783757
Start Date
August 1 2008
End Date
June 1 2017
Last Update
July 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114